Virtus LifeSci Biotech Clinical Trials ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-2.35%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-12.35%
Income- PEG- EPS next Q- Inst Own- Short Float / Ratio- / - Perf Quarter-6.34%
Sales- P/S- EPS this Y- Inst Trans- Short Interest- Perf Half Y-11.48%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-20.07%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range17.77 - 30.23 Perf YTD-9.27%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-25.00% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low27.59% ATR0.53
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)31.29 Volatility0.55% 1.31%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.00 Prev Close22.67
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume2.88K Price22.67
Recom- SMA20-6.38% SMA50-12.15% SMA200-8.79% Volume0 Change0.00%
Aug-30-21 04:00PM
Aug-20-20 05:25PM
May-27-20 09:40AM
May-11-20 01:00PM
01:40PM Loading…
Feb-10-20 01:40PM
Dec-31-19 08:00AM
Dec-27-19 02:19PM
Dec-26-19 02:30PM
Dec-24-19 12:15PM
Dec-23-19 12:00PM
Dec-20-19 02:00PM
01:41PM Loading…
Dec-18-19 01:41PM
Dec-17-19 03:31PM
Dec-16-19 10:42AM
Dec-12-19 08:00AM
Dec-10-19 04:16PM
Dec-04-19 09:40AM
Dec-03-19 02:30PM
Dec-02-19 11:10AM
Nov-29-19 12:15PM
Nov-25-19 08:00AM
Nov-21-19 12:56PM
Nov-04-19 10:10AM
Oct-30-19 10:43AM
10:10AM Loading…
Oct-23-19 10:10AM
Apr-25-19 10:00AM
Mar-12-19 11:05AM
Dec-27-18 02:30PM
Dec-21-18 02:30PM
Dec-18-18 10:55AM
Nov-20-18 10:25AM
Oct-23-18 09:18AM
Sep-04-18 01:00PM
Jul-12-18 04:53PM
Jul-10-18 12:15PM
Jul-09-18 02:37PM
May-15-18 12:15PM
Apr-18-18 04:08PM
Mar-14-18 05:39PM
Feb-02-18 08:00AM
Dec-25-17 06:00AM
Dec-22-17 04:16PM
Dec-19-17 03:00PM
Sep-11-17 10:29AM
Aug-30-17 01:08PM
Aug-28-17 02:37PM
Jun-30-17 11:30AM
Jun-29-17 03:37PM
Jun-23-17 02:43PM
Jun-22-17 11:17AM
Jun-16-17 08:00AM
May-15-17 03:26PM
Apr-28-17 09:30AM
Apr-27-17 10:03AM
Apr-03-17 10:59AM
Mar-31-17 09:30AM
Mar-30-17 11:22AM
Mar-29-17 10:09AM
Mar-22-17 10:51AM
Mar-21-17 12:19PM
Mar-08-17 10:07AM
Mar-01-17 01:24PM
Feb-28-17 12:00PM
Jan-12-17 10:08AM
Jan-11-17 06:54AM
Jan-03-17 10:36AM
Dec-30-16 07:02AM
Dec-27-16 10:42PM
Dec-16-16 02:51PM
Dec-07-16 02:11PM
Nov-17-16 09:30AM
Nov-16-16 09:51AM
Oct-27-16 12:19PM
Oct-03-16 04:31PM
Sep-30-16 09:13AM
Sep-21-16 11:23AM
Sep-19-16 04:09PM
Aug-18-16 09:30AM
Aug-10-16 09:30AM
Aug-09-16 02:01PM
Jul-21-16 11:08AM
Jul-20-16 02:23PM
Jun-22-16 10:40AM
Jun-21-16 02:07PM
Jun-16-16 02:35PM
Jun-07-16 09:30AM
Jun-03-16 10:10AM
May-16-16 06:58PM
Apr-28-16 12:15PM
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.